Effect of tiopronin combined with glutathione on biochemical indicators of patients with non-alcoholic fatty liver
10.12206/j.issn.1006-0111.202103002
- VernacularTitle:硫普罗宁联合谷胱甘肽治疗对非酒精性脂肪肝患者生化指标的影响
- Author:
Xiaona JIANG
1
;
Junjie PAN
2
;
Yanan YU
3
;
Zibin TIAN
3
Author Information
1. The Affiliated Hospital of Qingdao University, Qingdao 266000, China;Qingdao Special Servicemen Recuperation Center of the PLA Navy, Qingdao 266000, China.
2. Qingdao Special Servicemen Recuperation Center of the PLA Navy, Qingdao 266000, China.
3. The Affiliated Hospital of Qingdao University, Qingdao 266000, China.
- Publication Type:Medicine&Clinical
- Keywords:
tiopronin;
glutathione;
non-alcoholic fatty liver;
LN;
ALT;
AST
- From:
Journal of Pharmaceutical Practice
2021;39(5):465-467
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the effect of tiopronin combined with glutathione on the levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), glutamyltransferase (GGT),blood fat and laminin (LN) in patients with non-alcoholic fatty liver. Methods A total of 84 non-alcoholic fatty liver patients admitted to our hospital from March 2018 to September 2019 were selected and randomly divided into control group and observation group, with 42 cases in each group. The control group was treated with tiopronin, and the observation group was treated with glutathione and tiopronin. The levels of ALT, AST, GGT and blood fat were recorded and compared before and after treatment. Results After treatment, the levels of ALT, AST and GGT in the two groups were significantly lower than before treatment (P<0.05). After treatment, the levels of ALT, AST, and GGT in the observation group were different from those in the control group, which was statistically significant (P<0.05). Before treatment, there was no difference in serum TC, TG, and LDL levels between the two groups, which was not statistically significant (P>0.05). The above-mentioned serum levels of the observation group after treatment were lower than those in the control group, and there was a difference, which was statistically significant (P<0.05); the levels of PCⅢ, PCⅣ, and LN in the treatment group after treatment were significantly lower than those of the control group. The difference was statistically significant (P<0.05). Conclusion The application of tiopronin combined with glutathione in the treatment of non-alcoholic fatty liver can promote the recovery of liver function and reduce the concentrations of TC, TG and LDL, which is worthy of clinical promotion.
